Finally, given that our Hep3B and Huh7 cell line experiments do not fully recapitulate the tumor microenvironment, it will be essential to validate Rab5’s therapeutic potential using in vivo cancer HCC models. The gene discussed is RAB5A; the disease is hepatocellular carcinoma.